Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to National Comprehensive Cancer Network
Related studies linked through entity extraction aliases.
Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
- Status
- COMPLETED
- Phase
- PHASE1
Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.
- Status
- UNKNOWN
- Phase
- PHASE2
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- COMPLETED
- Phase
- PHASE1
Hepatic Arterial Infusion (HAI) of Abraxane
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early Prediction of Tumor Response
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
- Status
- COMPLETED
- Phase
- PHASE1